Neudle.com: glutamate receptors

Neurology Specific Literature Search

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

advances in neurology

adverse drug reaction

alveolar hypoventilation

Alzheimer's disease

Alzheimer's disease, treatment of

amnesia, anterograde

amnestic syndrome

AMPA receptor antibodies

amphiphysin antibodies

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, treatment of

anti GQ1b IgG antibody

anti Hu antibody

anti MAG antibodies

anti Ri antibody

anticholinesterase

arrhythmia, cardiac

ataxia, cerebellar

ataxia, progressive

ataxia, truncal

autoimmune basal ganglia encephalitis

autoimmune cerebellar ataxia

autoimmune disease

autoimmune encephalopathy

autoimmune epilepsy

automobile accidents

autonomic dysfunction

autonomic neuropathy

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavior, combative

behavioral disorder

behavioral disorder, acute

brainstem, lesion of

calcium antagonist

carcinoma of breast

carcinoma of lung

carcinoma of ovary

carcinoma of pancreas

CAT scan, chest

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, pelvis

celiac disease, adult

central nervous system, infection of

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar degeneration

cerebellar lesion

cerebellar peduncle

cerebellitis, autoimmune

cerebral cortex

cerebral embolism

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, pathophysiology

cerebrovascular accident, prevention of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of presentation

choreoathetosis

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

coma, medically induced

common variable immunodeficiency

conjugate gaze, forced

contactin associated protein like 2 antibodies

contractures, joint

controversies in neurology

conversion reaction

creatine phosphokinase(CPK)elevated

cyclophosphamide

cytochrome c oxidase

deep gray nuclei

degenerative diseases of CNS

dementia, reversible

dementia, treatment of

demyelinating disease

dermatomyositis

developmental milestones, loss of

diabetes mellitus

diagnostic criteria

differential diagnosis

disability, neurological

down-beat nystagmus

DPPX, antibodies

DPPX, antibodies, encephalitis

dura, thickened

dyskinesia, buccal lingual facial

dyskinesia, facial

electroencephalogram

electroencephalogram, abnormalities of

emotional lability

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, clinical picture and treatment of

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, unilateral

encephalitis, unknown etiology

encephalitis, viral

encephalitis, viral-causes of

encephalomyelitis

encephalomyelitis, autoimmune

encephalomyelitis, paraneoplastic

encephalopathy, Hashimoto's

encephalopathy, progressive

epidemiology of neurology

extralimbic encephalitis

extreme delta brush

eye movement, disorders of

face, numbness of

faciobrachial dystonic seizure

fibrinolytic agents

Fisher's syndrome

flu-like illness

gamma amino butyric acid

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gaze palsy, horizontal

glutamic acid decarboxylase, antibody

glycine receptor antibodies

Guillain Barre syndrome, variant forms of

gyrus, abnormal

hallucination, visual

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, recurrent

herpes simplex virus

hippocampal atrophy

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

hyperthyroidism

hypoxic encephalopathy

immune checkpoint inhibitors

immune-related adverse events

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

internuclear ophthalmoplegia, bilateral

ischemic penumbra

Jakob-Creutzfeldt disease

laughing, pathologic

leg spasms, painful

leg weakness, bilateral

leucine rich glioma inactivated 1 antibodies

level of consciousness

level of consciousness, decreased

life expectancy

limbic encephalitis

lymphoma involving CNS

malignancy screen

malignancy, occult

mediastinum, mass of

memory, defect of recent

memory, impairment of

meningeal enhancement

mental status, abnormal

mesial temporal lobe

mesial temporal sclerosis

mGlu R5 antibodies

migraine, children

migraine, pathogenesis

monoclonal antibodies

Morvan's fibrillary chorea

motor neuron disease

movement disorder

movement disorder, extrapyramidal

movement disorder, psychogenic

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, spinal cord

multiple sclerosis

muscle stiffness

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

myoclonus, segmental

nausea and vomiting

neurexin-3 alpha antibodies

neuroendocrinology

neurologic complications

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic examination, focal

neurologic signs

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromyelitis optica (Devic's disease)

neuromyelitis optica, IgG

neuronal cell surface antigen

neuronopathy, sensory

neuroophthalmology

neuropathology, brain

neuropathy, paraneoplastic

neuroprotective agents

neurotransmitter

NMDA antagonist, late onset

NMDA antagonists

noncommunicative

novel cell-membrane antigens

nystagmus, upbeating on upgaze

nystagmus, vertical

old age, neurology of

olivary degeneration, hypertrophic

onconeural antibodies

ophelia syndrome

ophthalmoplegia

opsoclonus-myoclonus syndrome

overlap syndrome

pachymeningitis, cranial

palatal myoclonus

paraneoplastic brainstem encephalitis

paraneoplastic cerebellar degeneration

paraspinal muscle

Parkinson disease

Parkinson disease, treatment of

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

paroxysmal neurologic disorder

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

peripheral nerve, lesion of

personality change

pleocytosis of cerebrospinal fluid

pons, lesion of

post herpes simplex encephalitis immune-mediated relapse

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

prevention of neurologic disorders

progressive encephalomyelitis with rigidity syndrome

progressive neurologic disorder

psychiatric problems in neurologic disorders

psychosis, acute

psychosis, childhood

psychotic behavior

pupil, abnormality in neurologic disorders

Purkinje cell surface antibody

pyramidal tract

rabies, nervous system involvement with

release phenomena

remote effect of cancer on the nervous system

reversal of sleep wake cycle

reversible neurologic disorder

salivation, excessive

Schmidt syndrome

seizure, adult onset

seizure, drug resistance

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, unknown origin

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

sexual behavior, disorder of

sleep pathology and physiology

speech disorder

speech disorder, childhood

spinal cord, cervical

spinal cord, lesion of

standing difficulty

startle reaction

status epilepticus

status epilepticus, nonconvulsive

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

stiff limb syndrome

stiff man syndrome

stiff man syndrome, variant

stress, emotional

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

stroke, progression of

superior cerebellar peduncle

sweating, abnormality of

symmetric brain lesions

syphilis, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma, ovarian

testicular teratoma

thrombocytopenia

thyroid function tests

tissue plasminogen activator, intravenous

tone, muscle, increased

tongue, protrusion of

transient ischemic attack

treatment of neurologic disorder

triangle of Guillain and Mollaret

unconsciousness

urinary retention

varicella zoster virus

violent behavior

viral infection

viral infection, CNS

vision, blurred

walking, difficulty with

white matter disease

white matter disease, subcortical

wide based gait

Showing articles 650 to 700 of 787 << Previous Next >>

Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987

Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987

Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987

Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987

Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986

Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986

The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986

The Pathophysiology of Penicillamine-Induced Myasthenia Gravis
Ann Neurol 20:740-744, Kuncl,R.W.,et al, 1986

Opsoclonus in Adults
Arch Neurol 43:1165-1175, Digre,K.B., 1986

Glutamate & the Pathophysiology of Hypoxic-Ischemic Brain Damage
Ann Neurol 19:105-111, Rothman,S.M.&Olney,J.W., 1986

The Diagnosis of Myasthenia Gravis
Editorial, Lancet 1:658-6601986., , 1986

Myasthenia Gravis without Acetylcholine-Receptor Antibody:A Distinct Disease Entity
Lancet 1:116-118, Mossman,S.,et al, 1986

Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986

Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986

Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986

Muscarinic Acetylcholine Receptors in Alzheimer's Disease
JAMA 254:3063-3066, Holman,B.L.,et al, 1985

Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985

Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985

Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985

Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985

Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985

Clin. Path. Conference
Limbic Encephalitis (Paraneoplastic Encephalomyelitis) , Transitional-Cell CA of Urinary Bladder, Ca, e Re 30-1985,NEJM 313:249-257,1985., 1985

Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985

Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985

Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985

Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985

Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985

Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985

Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985

Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984

Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984

Metoclopramide & Tardive Dyskinesia in the Elderly
BMJ 289:397-398, Orme,M.L., 1984

Treatment of Tourette's Syndrome with R022-1913, A D-2-Receptor Antagonist
NEJM 311:989, Uhr,S.B.,et al, 1984

Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984

Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984

Neurological Disorders Associated with Deficiency of Glutamate Dehydrogenase
Ann Neurol 15:144-153, Plaitakis,A.,et al, 1984

Prolonged Metoclopramide-Induced Dyskinetic Reaction
Neurol 34:238-239, Leopold,N.A., 1984

Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984

Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984

Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984

Hyperprolactinemia
Am J Med 75:868-874, Johnston,D.G.,et al, 1983

Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983

Limbic Encephalopathy as a Nonmetastatic Complication of Oat Cell Lung Cancer
Am J Med 75:518-520, Brennan,L.V.,et al, 1983

Pergolide in Parkinson's Disease
Arch Neurol 40:785-787, Goetz,C.G.,et al, 1983

Myoclonus Induced by Metoclopramide Therapy
Arch Int Med 143:2201-2202, Hyser,C.G.,et al, 1983

Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983

Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983

Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983

Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983

Comparison of Pergolide & Bromocriptine Therapy in Parkinsonism
Neurol 33:1009-1014, LeWitt,P.A.,et al, 1983

Showing articles 650 to 700 of 787 << Previous Next >>